Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Cash from Operations (2019 - 2025)

Silo Pharma's Cash from Operations history spans 7 years, with the latest figure at 955493.0 for Q3 2025.

  • For Q3 2025, Cash from Operations rose 29.04% year-over-year to 955493.0; the TTM value through Sep 2025 reached 4798493.0, down 25.4%, while the annual FY2024 figure was 3833914.0, 18.9% down from the prior year.
  • Cash from Operations for Q3 2025 was 955493.0 at Silo Pharma, up from 1285268.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 319318.0 in Q1 2021 and bottomed at 1640300.0 in Q1 2025.
  • The 5-year median for Cash from Operations is 838179.0 (2024), against an average of 879742.68.
  • The largest annual shift saw Cash from Operations crashed 171.51% in 2021 before it grew 29.04% in 2025.
  • A 5-year view of Cash from Operations shows it stood at 773871.0 in 2021, then decreased by 14.49% to 885989.0 in 2022, then decreased by 2.71% to 910012.0 in 2023, then fell by 0.82% to 917432.0 in 2024, then decreased by 4.15% to 955493.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Cash from Operations are 955493.0 (Q3 2025), 1285268.0 (Q2 2025), and 1640300.0 (Q1 2025).